Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Prolymphocytic × Alemtuzumab × 90 days × Clear all

Sponsor

Conditions

Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pseudomyxoma Peritonei 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Melanoma 1 Lymphoma 1 Digestive System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Adenocarcinoma, Clear Cell 1

Interventions

fludarabine 3 Whole-Body Irradiation 3 Cyclophosphamide 3 fludarabine phosphate 2 Mycophenolic Acid 2 Cyclosporine 2 treosulfan 1 acalabrutinib 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Stem Cell Transplantation 1 Polymerase Chain Reaction 1 Peripheral Blood Stem Cell Transplantation 1 Patient Reported Outcome Measures 1 Mesna 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Granulocyte Colony-Stimulating Factor 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Filgrastim 1 Dasatinib 1 Cyclosporins 1 Busulfan 1 Antiviral Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡